warnings about liver problems in patients taking Accolate (zafirlukast)
February 2003
There are now stronger warnings about liver problems in patients taking Accolate (zafirlukast).
Severe hepatitis is rare...but about 5% of patients can get elevated liver enzymes without any symptoms.
Counsel patients on Accolate to report signs of liver toxicity...fatigue, abdominal pain, jaundice, etc.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote